QI
AZN icon

Qtron Investments’s AstraZeneca AZN Stock Holding History

Qtron Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
11,190
-3,800
-25% -$715K 0.28% 58
2026
Q1 		$2.96M Buy
14,990
+5
+0% +$964 0.4% 40
2025
Q4 		$2.76M Sell
14,985
-851
-5% -$149K 0.36% 44
2025
Q3 		$2.43M Sell
15,836
-885
-5% -$134K 0.3% 61
2025
Q2 		$2.34M Sell
16,721
-559
-3% -$78.3K 0.3% 59
2025
Q1 		$2.54M Buy
17,280
+1,157
+7% +$167K 0.38% 42
2024
Q4 		$2.11M Sell
16,123
-483
-3% -$67.6K 0.3% 54
2024
Q3 		$2.59M Sell
16,606
-594
-3% -$95.9K 0.35% 46
2024
Q2 		$2.68M Buy
17,200
+897
+6% +$135K 0.39% 41
2024
Q1 		$2.21M Buy
16,303
+3,061
+23% +$405K 0.31% 56
2023
Q4 		$1.78M Buy
13,242
+1,070
+9% +$139K 0.29% 66
2023
Q3 		$1.65M Sell
12,172
-4,412
-27% -$603K 0.31% 64
2023
Q2 		$2.37M Buy
16,584
+2,107
+15% +$310K 0.45% 48
2023
Q1 		$2.01M Buy
14,477
+872
+6% +$117K 0.41% 51
2022
Q4 		$1.84M Buy
13,605
+2,035
+18% +$255K 0.39% 57
2022
Q3 		$1.27M Buy
11,570
+1,310
+13% +$166K 0.32% 72
2022
Q2 		$1.36M Hold
10,260
– – 0.3% 74
2022
Q1 		$1.36M Sell
10,260
-938
-8% -$112K 0.3% 79
2021
Q4 		$1.3M Sell
11,198
-13
-0.1% -$1.53K 0.29% 83
2021
Q3 		$1.35M Buy
11,211
+3,510
+46% +$409K 0.36% 60
2021
Q2 		$923K Buy
7,701
+2,790
+57% +$306K 0.23% 112
2021
Q1 		$488K Sell
4,911
-2,487
-34% -$250K 0.14% 199
2020
Q4 		$740K Hold
7,398
– – 0.2% 118
2020
Q3 		$811K Hold
7,398
– – 0.28% 77
2020
Q2 		$783K Buy
7,398
+752
+11% +$77.7K 0.31% 77
2020
Q1 		$594K Buy
6,646
+4,367
+192% +$411K 0.36% 88
2019
Q4 		$227K Buy
+2,279
New +$215K 0.13% 200

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qtron Investments's AZN Position: Q2 2026 in Review

Qtron Investments reduced its AstraZeneca (AZN) stake by 25% in Q2 2026, selling an estimated $715K and leaving 11,190 shares worth $2.12M. The position accounts for 0.28% of the portfolio, ranked #58.

Qtron Investments first reported a position in AZN in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.96M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Qtron Investments held 11,190 shares of AstraZeneca worth $2.12M as of Q2 2026.
  • Qtron Investments sold 3,800 AstraZeneca shares in Q2 2026, an estimated $715K.
  • AstraZeneca made up 0.28% of Qtron Investments's portfolio in Q2 2026, its #58 holding.
  • Qtron Investments first reported a position in AstraZeneca in Q4 2019 and has held it in 27 quarters since.
  • Qtron Investments's AstraZeneca position peaked at $2.96M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.